Description
A synthetic oxysterol and LXR modulator; decreases triacylglycerol and diacylglycerol synthesis from labeled palmitate and acetate, respectively, in human myoblasts by 50% (10 µM); reduces FASN reporter activity through an LXR response element in the promoter region in COS-1 cells; dietary supplementation leads to less body weight gain and lower liver triacylglycerol levels in rats fed regular chow or a high-fat diet (30 mg/kg per day)
Formal name: cholest-5-ene-3β,22S-diol
Synonyms: 22β-hydroxy Cholesterol
Molecular weight: 402.7
CAS: 22348-64-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Receptor Pharmacology|Allosteric Modulators||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Hormones & Receptors|FXRs & LXRs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity||Research Area|Lipid Biochemistry|Glycerolipids||Research Area|Lipid Biochemistry|Sterol Lipids